Adaptin Bio APTN Income Statement (2022-2026)

OTC APTN
$6.27 +0.02 (+0.32%)
At close: Aug 3, 2026 · 4:00 PM UTC
Income Statement Dec2022 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating items
Research & Development (Quarter) 0.20M0.69M0.68M0.26M0.06M0.34M0.78M0.59M0.17M0.14M
Selling, General & Administrative (Quarter) 0.04M0.03M0.10M0.08M0.31M0.25M0.79M1.18M0.90M0.77M0.98M1.06M
Restructuring Costs (Quarter) 0.18M
Other Operating Expenses (Quarter) -0.18M
Operating Expenses (Quarter) 0.04M0.03M0.30M0.77M0.99M0.51M0.85M1.52M1.68M1.37M1.14M1.20M
Operating Income (Quarter) -0.04M-0.03M-0.30M-0.77M-0.99M-0.51M-0.85M-1.52M-1.68M-1.37M-1.14M-1.20M
EBIT (Quarter) -0.04M-0.03M-0.30M-0.77M-0.99M-0.51M-0.85M-1.52M-1.68M-1.37M-1.14M-1.20M
Non-operating items
Other Non Operating Income (Quarter) -133.00-0.00M-0.01M-0.19M-0.01M0.33M0.33M
Non Operating Income (Quarter) -0.04M-0.05M-0.11M-0.35M0.25M-0.00M-0.00M
Net income details
EBT (Quarter) -0.04M-0.07M-0.34M-0.82M-1.11M-0.83M-0.60M-1.52M-1.68M-1.37M-1.15M-1.21M
Profit After Tax (Quarter) -0.04M-0.03M-0.34M-0.82M-1.11M-0.86M-0.60M-1.52M-1.68M-1.37M-1.15M-1.21M
Income from Continuing Operations (Quarter) -0.04M-0.07M-0.34M-0.82M-1.11M-0.83M-0.60M-1.52M-1.68M-1.37M-1.15M-1.21M
Consolidated Net Income (Quarter) -0.04M-0.07M-0.34M-0.82M-1.11M-0.83M-0.60M-1.52M-1.68M-1.37M-1.15M-1.21M
Income towards Parent Company (Quarter) -0.04M-0.07M-0.34M-0.82M-1.11M-0.83M-0.60M-1.52M-1.68M-1.37M-1.15M-1.21M
Net Income towards Common Stockholders (Quarter) -0.04M-0.07M-0.34M-0.82M-1.11M-0.83M-0.60M-1.52M-1.68M-1.37M-1.15M-1.21M
Additional items
EPS (Basic) (Quarter) -0.01-0.01-0.07-0.16-0.22-0.17-0.10-0.18-0.20-0.18-0.13-0.14
EPS (Diluted) (Quarter) -0.01-0.01-0.07-0.16-0.22-0.17-0.10-0.18-0.20-0.18-0.13-0.14
Shares Outstanding (Quarter) 5.00M5.00M5.00M5.00M5.00M5.00M5.00M5.83M8.45M8.46M7.81M8.70M8.85M
Shares Outstanding (Diluted) (Quarter) 5.00M5.00M5.00M5.00M5.00M5.00M5.00M5.83M8.45M8.46M7.81M8.70M8.85M
Shares Outstanding (Entity) (Quarter) 5.00M5.00M5.00M5.00M5.00M5.00M5.00M5.83M8.46M8.46M8.66M8.79M9.23M
EBITDA (Quarter) -0.04M-0.03M-0.30M-0.77M-0.99M-0.51M-0.85M-1.52M-1.68M-1.37M-1.14M-1.20M
Interest Expenses (Quarter) 0.01M0.04M0.04M0.05M0.11M0.15M0.07M0.00M0.00M